
  
    
      
        Introduction_NNP
        Public_JJ health_NN agencies_NNS ,_, medical_JJ care_NN delivery_NN systems_NNS ,_,
        and_CC clinicians_NNS all_DT depend_VBP on_IN accurate_JJ and_CC timely_JJ
        information_NN about_IN disease_NN occurrence_NN to_TO guide_VB planning_NN ,_,
        resource_NN allocation_NN ,_, and_CC case_NN management_NN ._. In_IN the_DT public_JJ
        health_NN arena_NN ,_, the_DT current_JJ United_NNP States_NNPS infectious_JJ disease_NN
        surveillance_NN infrastructure_NN was_VBD recently_RB the_DT subject_NN of_IN an_DT
        extensive_JJ review_NN by_IN the_DT US_NNP Department_NNP of_IN Health_NNP and_CC Human_NNP
        Services_NNPS [_NN 1_CD ]_NN ._. That_DT review_NN identified_VBD substantial_JJ
        weaknesses_NNS in_IN existing_VBG capacity_NN to_TO detect_VB four_CD major_JJ
        threats_NNS to_TO public_JJ health_NN -_: emerging_VBG infections_NNS ,_,
        antimicrobial_NN resistance_NN ,_, bioterrorism_NN ,_, and_CC pandemic_JJ
        influenza_NN ._. A_DT major_JJ recommendation_NN of_IN that_DT report_NN was_VBD to_TO
        engage_VB with_IN the_DT health_NN care_NN delivery_NN system_NN as_IN a_DT partner_NN in_IN
        surveillance_NN ._. Specifically_RB ,_, it_PRP made_VBD a_DT "_'' level_NN 1_CD "_''
        recommendation_NN for_IN funding_NN of_IN efficient_JJ ,_, easy-to-use_JJ ,_, and_CC
        rapid_JJ automated_VBN reporting_VBG systems_NNS based_VBN on_IN national_JJ
        standards_NNS ._. Such_JJ automated_VBN reporting_VBG systems_NNS can_MD take_VB two_CD
        basic_JJ forms_NNS -_: they_PRP can_MD facilitate_VB clinicians_NNS '_POS active_JJ
        reporting_NN of_IN individual_JJ cases_NNS of_IN diseases_NNS of_IN interest_NN ,_, or_CC
        they_PRP can_MD use_VB some_DT of_IN the_DT extensive_JJ information_NN that_WDT is_VBZ
        already_RB collected_VBN in_IN automated_VBN form_NN in_IN the_DT process_NN of_IN
        medical_JJ care_NN delivery_NN or_CC in_IN administration_NN of_IN medical_JJ care_NN
        benefits_NNS ._.
        We_PRP focus_VBP here_RB on_IN an_DT example_NN of_IN the_DT latter_JJ approach_NN ,_,
        assessing_VBG automated_VBN information_NN about_IN diagnoses_NNS assigned_VBN by_IN
        clinicians_NNS during_IN ambulatory_JJ care_NN visits_NNS ._. To_TO our_PRP$ knowledge_NN ,_,
        automated_VBN medical_JJ record_NN information_NN has_VBZ not_RB been_VBN used_VBN for_IN
        rapid_JJ surveillance_NN purposes_NNS ._. Such_JJ an_DT approach_NN has_VBZ several_JJ
        potential_JJ advantages_NNS ._. These_DT include_VBP the_DT facts_NNS that_IN it_PRP
        imposes_VBZ no_DT reporting_VBG burden_NN on_IN clinicians_NNS and_CC avoids_VBZ the_DT
        reporting_VBG biases_NNS inherent_JJ in_IN spontaneous_JJ reports_NNS ,_, and_CC the_DT
        data_NNS can_MD be_VB available_JJ promptly_RB ._. In_IN addition_NN ,_, they_PRP can_MD
        assess_VB the_DT very_RB large_JJ number_NN of_IN cases_NNS of_IN illness_NN for_IN which_WDT
        no_DT etiologic_JJ diagnosis_NN exists_VBZ ,_, and_CC which_WDT are_VBP therefore_RB
        typically_RB not_RB reportable_JJ ._. These_DT illness_NN syndromes_NNS can_MD be_VB of_IN
        interest_NN because_IN they_PRP might_MD provide_VB several_JJ days_NNS '_POS advance_NN
        warning_NN of_IN a_DT serious_JJ problem_NN ,_, such_JJ as_IN anthrax_NN ,_, and_CC also_RB
        because_IN they_PRP make_VBP use_NN of_IN the_DT large_JJ body_NN of_IN information_NN in_IN
        encounters_VBZ for_IN which_WDT no_DT diagnostic_JJ testing_NN is_VBZ performed_VBN ._.
        Currently_RB ,_, this_DT information_NN is_VBZ typically_RB unavailable_JJ for_IN
        epidemiologic_JJ purposes_NNS ,_, although_IN the_DT tracking_NN of_IN influenza_NN
        like_IN illness_NN in_IN sentinel_NN practices_NNS is_VBZ an_DT example_NN of_IN such_JJ
        syndromic_JJ surveillance_NN ._.
        The_DT automated_VBN medical_JJ records_NNS of_IN health_NN plans_NNS and_CC large_JJ
        group_NN practices_NNS are_VBP an_DT especially_RB useful_JJ source_NN of_IN
        surveillance_NN data_NNS because_IN they_PRP serve_VBP a_DT well-defined_JJ
        population_NN of_IN members_NNS ,_, they_PRP have_VBP responsibility_NN for_IN most_JJS
        aspects_NNS of_IN health_NN care_NN ,_, and_CC they_PRP routinely_RB collect_VBP
        clinical_JJ ,_, demographic_JJ and_CC accounting_NN data_NNS ._. This_DT paper_NN
        describes_VBZ some_DT of_IN the_DT technical_JJ and_CC methodological_JJ issues_NNS
        encountered_VBD in_IN developing_VBG a_DT surveillance_NN system_NN for_IN lower_JJR
        respiratory_JJ infection_NN based_VBN on_IN automated_VBN ambulatory_JJ care_NN
        electronic_JJ encounter_NN records_NNS from_IN a_DT large_JJ HMO_NNP and_CC
        multi-specialty_JJ group_NN practice_NN ._.
      
      
        Methods_NNP
        We_PRP studied_VBD information_NN in_IN the_DT automated_VBN medical_JJ records_NNS ,_,
        demographic_JJ ,_, and_CC eligibility_NN records_NNS of_IN individuals_NNS cared_VBD
        for_IN by_IN Harvard_NNP Vanguard_NNP Medical_NNP Associates_NNPS (_( HVMA_NNP )_) ,_, a_DT large_JJ
        multi-specialty_JJ group_NN practice_NN in_IN eastern_JJ Massachusetts_NNP ._. At_IN
        the_DT beginning_NN of_IN the_DT study_NN period_NN ,_, HVMA_NNP was_VBD a_DT staff_NN model_NN
        component_NN of_IN Harvard_NNP Pilgrim_NNP Health_NNP Care_NNP (_( HPHC_NNP )_) ,_, a_DT
        not-for-profit_JJ HMO_NNP ,_, and_CC all_DT individuals_NNS studied_VBN were_VBD
        members_NNS of_IN Harvard_NNP Pilgrim_NNP ._. Ambulatory_NNP care_NN ,_, including_VBG
        scheduled_VBN ,_, same_JJ day_NN ,_, and_CC urgent_JJ care_NN visits_NNS ,_, is_VBZ delivered_VBN
        in_IN fourteen_CD health_NN centers_NNS in_IN greater_JJR Boston_NNP ._. Urgent_NNP care_NN
        visits_NNS include_VBP many_JJ of_IN the_DT encounters_NNS that_WDT are_VBP cared_VBN for_IN in_IN
        hospital_NN emergency_NN rooms_NNS in_IN other_JJ practice_NN settings_NNS ._. All_DT
        individuals_NNS included_VBN in_IN this_DT study_NN were_VBD HMO_NNP members_NNS who_WP had_VBD
        a_DT strong_JJ financial_JJ incentive_NN to_TO receive_VB their_PRP$ care_NN at_IN one_CD
        of_IN these_DT health_NN centers_NNS ._.
        Care_NNP in_IN the_DT health_NN centers_NNS is_VBZ delivered_VBN using_VBG automated_VBN
        medical_JJ records_NNS ._. At_IN present_JJ ,_, Epicare_NNP ,_, a_DT commercially_RB
        available_JJ system_NN is_VBZ used_VBN ._. Clinicians_NNP assign_VB diagnoses_NNS for_IN
        each_DT visit_NN from_IN lists_NNS that_WDT correspond_VB to_TO ICD_NNP 9_CD CM_NNP codes_NNS [_NN 2_CD ]_NN
        ._. The_DT system_NN also_RB contains_VBZ vital_JJ signs_NNS and_CC all_DT providers_NNS '_POS
        full_JJ text_NN notes_NNS ._. An_DT earlier_JJR automated_VBN medical_JJ record_NN system_NN
        in_IN use_NN during_IN the_DT first_JJ part_NN of_IN the_DT study_NN period_NN used_VBD
        COSTAR_NNP [_NN 3_CD ]_NN diagnosis_NN codes_NNS ,_, which_WDT we_PRP mapped_VBN to_TO ICD_NNP 9_CD CM_NNP
        codes_NNS ._. Individual_JJ patient_NN identifiers_NNS were_VBD replaced_VBN with_IN
        study-specific_JJ ,_, encrypted_JJ unique_JJ identifiers_NNS before_IN the_DT
        data_NNS were_VBD made_VBN available_JJ for_IN analysis_NN ._. The_DT study_NN was_VBD
        approved_VBN by_IN the_DT HPHC_NNP Institutional_NNP Review_NNP Board_NNP ._.
        A_DT total_NN of_IN 7_CD ,_, 265_CD ,_, 523_CD encounter_VB records_NNS ,_, including_VBG
        routine_JJ ,_, scheduled_VBN ,_, and_CC urgent_JJ care_NN visits_NNS ,_, plus_CC telephone_NN
        calls_VBZ that_IN clinicians_NNS chose_VBD to_TO record_VB ,_, were_VBD collected_VBN
        during_IN the_DT four_CD years_NNS between_IN the_DT beginning_NN of_IN 1996_CD and_CC the_DT
        end_NN of_IN 1999_CD ._. Each_DT encounter_NN was_VBD coded_VBN by_IN the_DT physician_NN at_IN
        the_DT time_NN of_IN consultation_NN with_IN up_IN to_TO 11_CD diagnosis_NN codes_NNS ._. The_DT
        proportion_NN of_IN visits_NNS assigned_VBN multiple_JJ ICD_NNP 9_CD CM_NNP codes_NNS
        decreased_VBD steeply_RB after_IN the_DT first_JJ two_CD of_IN these_DT ,_, ranging_VBG
        from_IN 10_CD ._. 2_LS %_NN (_( 744_CD ,_, 290_CD )_) of_IN visits_NNS with_IN three_CD codes_NNS and_CC 7_CD ._. 4_CD %_NN
        (_( 540_CD ,_, 049_CD )_) of_IN visits_NNS with_IN four_CD codes_NNS ,_, to_TO 0_CD %_NN (_( 0_CD )_) with_IN eleven_CD ._.
        Since_IN we_PRP were_VBD interested_JJ in_IN a_DT primary_JJ diagnosis_NN of_IN lower_JJR
        respiratory_JJ infection_NN ,_, we_PRP considered_VBD only_RB the_DT first_JJ two_CD
        diagnostic_JJ codes_NNS ._. Emergency_NN room_NN visits_NNS were_VBD excluded_VBN for_IN
        two_CD primary_JJ reasons_NNS :_: they_PRP are_VBP not_RB uniformly_RB captured_VBN ,_, and_CC
        they_PRP enter_VBP the_DT system_NN after_IN some_DT delay_NN ,_, thereby_RB greatly_RB
        diminishing_VBG their_PRP$ utility_NN for_IN any_DT real_JJ time_NN surveillance_NN
        system_NN ._.
        Membership_NN data_NNS for_IN the_DT same_JJ period_NN were_VBD extracted_VBN from_IN
        administrative_JJ data_NNS systems_NNS ._. The_DT number_NN of_IN days_NNS of_IN
        membership_NN over_IN the_DT four_CD years_NNS of_IN the_DT study_NN for_IN each_DT
        individual_JJ member_NN was_VBD determined_VBN ._. These_DT were_VBD summed_VBD by_IN age_NN
        and_CC gender_NN and_CC used_VBN as_IN the_DT denominators_NNS for_IN calculating_VBG
        crude_NN and_CC age_NN /_NN gender_NN specific_JJ incidence_NN rates_NNS ._.
        ICD_NNP 9_CD CM_NNP codes_NNS were_VBD grouped_VBN into_IN syndromes_NNS for_IN the_DT
        purposes_NNS of_IN the_DT main_JJ analysis_NN ._. A_DT provisional_JJ set_NN of_IN ICD_NNP 9_CD CM_NNP
        codes_NNS for_IN Lower_JJR Respiratory_JJ Infection_NNP (_( LRI_NNP )_) currently_RB in_IN
        use_NN (_( personal_JJ communication_NN ,_, J_NNP ._. Pavlin_NNP ;_: Appendix_NNP 1_LS )_) by_IN the_DT
        US_NNP Department_NNP of_IN Defense_NNP ESSENCE_NNP project_NN [_NN 4_CD ]_NN were_VBD used_VBN ._.
        Any_DT encounter_NN record_NN with_IN one_CD of_IN the_DT relevant_JJ codes_NNS in_IN
        either_DT of_IN the_DT first_JJ two_CD ICD_NNP 9_CD CM_NNP codes_NNS assigned_VBN during_IN an_DT
        encounter_NN was_VBD selected_VBN for_IN analysis_NN ._.
        After_IN selecting_VBG all_DT LRI_NNP records_NNS ,_, encounters_VBZ for_IN each_DT
        individual_NN were_VBD grouped_VBN into_IN episodes_NNS of_IN illness_NN on_IN the_DT
        assumption_NN that_IN for_IN any_DT individual_JJ patient_NN ,_, a_DT subsequent_JJ
        visit_NN for_IN LRI_NNP within_IN six_CD weeks_NNS of_IN a_DT preceding_VBG LRI_NNP visit_NN
        would_MD be_VB likely_JJ to_TO represent_VB follow-up_JJ for_IN the_DT same_JJ
        infection_NN ,_, whereas_IN widely_RB separated_JJ LRI_NNP visits_NNS probably_RB
        represented_VBD separate_JJ events_NNS ._. The_DT data_NNS supporting_VBG the_DT six_CD
        week_NN cut_NN off_RP is_VBZ shown_VBN below_IN ._.
        After_IN these_DT analyses_NNS were_VBD completed_VBN ,_, the_DT health_NN plan_NN
        discovered_VBN that_IN some_DT clinical_JJ data_NN were_VBD missing_VBG in_IN master_NN
        files_NNS from_IN which_WDT the_DT analysis_NN datasets_NNS were_VBD created_VBN ._.
        Membership_NN information_NN was_VBD not_RB affected_VBN by_IN this_DT problem_NN ._.
        Corrected_NNP data_NNS were_VBD not_RB expected_VBN to_TO be_VB available_JJ for_IN
        several_JJ months_NNS ._. Analysis_NNP of_IN a_DT random_JJ sample_NN of_IN 500_CD
        individuals_NNS '_POS data_NNS showed_VBD that_IN the_DT results_NNS reported_VBD here_RB
        undercount_NN individuals_NNS with_IN LRI_NNP ,_, LRI_NNP episodes_NNS ,_, and_CC LRI_NNP
        encounters_VBZ by_IN less_JJR than_IN 10_CD %_NN ,_, with_IN no_DT identified_VBN pattern_NN to_TO
        the_DT missing_VBG information_NN ._. The_DT data_NNS are_VBP therefore_RB presented_VBN
        with_IN the_DT understanding_NN that_IN complete_JJ figures_NNS would_MD include_VB
        an_DT additional_JJ 10_CD %_NN of_IN counts_NNS ;_: this_DT difference_NN should_MD not_RB
        affect_VB the_DT substantive_JJ conclusions_NNS ._.
      
      
        Results_NNS
        There_EX were_VBD 501_CD ,_, 323_CD individuals_NNS who_WP were_VBD members_NNS for_IN at_IN
        least_JJS part_NN of_IN the_DT four_CD year_NN study_NN period_NN and_CC thus_RB eligible_JJ
        to_TO present_VB for_IN ambulatory_JJ care_NN ._. The_DT median_JJ duration_NN of_IN
        membership_NN was_VBD 2_CD ._. 2_CD years_NNS (_( mean_VB =_SYM 2_CD ._. 3_CD years_NNS ,_, s_VBZ ._. d_SYM ._. =_SYM 1_CD ._. 5_CD
        years_NNS )_) ,_, yielding_VBG 1_CD ,_, 143_CD ,_, 208_CD person-years_JJ of_IN observation_NN ._. The_DT
        age_NN and_CC sex_NN distribution_NN of_IN observation_NN time_NN is_VBZ shown_VBN in_IN
        Table_NNP 1_CD ._.
        During_IN this_DT time_NN ,_, 152_CD ,_, 435_CD ambulatory_JJ care_NN encounters_NNS
        were_VBD assigned_VBN one_CD or_CC more_JJR of_IN the_DT codes_NNS in_IN the_DT LRI_NNP syndrome_NN
        definition_NN (_( see_VB Appendix_NNP 1_LS )_) ._. Although_IN 119_CD different_JJ ICD_NNP 9_CD CM_NNP
        diagnoses_NNS contribute_VBP to_TO the_DT lower_JJR respiratory_JJ syndrome_NN
        category_NN ,_, three_CD codes_NNS accounted_VBD for_IN more_JJR than_IN 90_CD %_NN of_IN all_DT
        encounters_VBZ (_( Table_NNP 2_LS )_) ._. These_DT codes_NNS were_VBD cough_NN (_( ICD_NNP 9_CD CM_NNP
        786_CD ._. 2_LS )_) ,_, pneumonia_NN not_RB otherwise_RB specified_VBN (_( ICD_NNP 9_CD CM_NNP 486_CD )_) ,_, and_CC
        acute_JJ bronchitis_NNS (_( ICD_NNP 9_CD CM_NNP 466_CD ._. 0_CD )_) ._. Notably_RB ,_, these_DT are_VBP codes_NNS
        that_IN clinicians_NNS can_MD assign_VB without_IN performing_VBG laboratory_NN
        testing_NN ._.
        The_DT 152_CD ,_, 435_CD LRI_NNP encounters_NNS were_VBD attributable_JJ to_TO 75_CD ,_, 747_CD
        individual_JJ members_NNS who_WP experienced_VBD a_DT mean_NN of_IN 2_CD ._. 0_CD encounters_VBZ
        each_DT (_( minimum_JJ =_SYM 1_CD ,_, maximum_NN =_SYM 65_CD )_) ._. More_JJR than_IN half_NN of_IN these_DT
        individuals_NNS (_( n_NN =_SYM 43_CD ,_, 404_CD )_) had_VBD exactly_RB one_CD LRI_NNP encounter_VB ._. For_IN
        the_DT 32_CD ,_, 343_CD individuals_NNS with_IN more_JJR than_IN one_CD LRI_NNP encounter_VB ,_,
        the_DT distribution_NN of_IN intervals_NNS between_IN LRI_NNP encounters_VBZ is_VBZ
        shown_VBN in_IN Figure_NN 1_CD ._. In_IN more_JJR than_IN half_NN of_IN individuals_NNS with_IN
        multiple_JJ LRI_NNP encounters_VBZ ,_, a_DT second_JJ encounter_NN occurred_VBD less_JJR
        than_IN three_CD weeks_NNS after_IN the_DT first_JJ ._. Approximately_RB 8_CD ,_, 000_CD
        members_NNS had_VBD a_DT second_JJ encounter_NN more_JJR than_IN one_CD year_NN after_IN the_DT
        first_JJ ._. To_TO avoid_VB double_JJ counting_NN of_IN ambulatory_JJ care_NN
        encounters_VBZ that_WDT were_VBD really_RB part_NN of_IN the_DT same_JJ episode_NN of_IN
        infection_NN ,_, we_PRP used_VBD a_DT criterion_NN based_VBN on_IN clinical_JJ experience_NN
        together_RB with_IN the_DT distribution_NN shown_VBN in_IN Figure_NN 1_CD ._. If_IN any_DT
        individual_JJ member_NN had_VBD more_JJR than_IN one_CD LRI_NNP encounter_VB ,_, we_PRP
        required_VBD 6_CD weeks_NNS free_JJ of_IN any_DT LRI_NNP diagnosis_NN encounter_NN before_IN
        attributing_VBG a_DT new_JJ episode_NN of_IN LRI_NNP illness_NN to_TO that_DT
        individual_NN ._. Using_VBG this_DT criterion_NN ,_, the_DT 152_CD ,_, 435_CD encounters_VBZ
        for_IN LRI_NNP were_VBD reduced_VBN to_TO 106_CD ,_, 670_CD distinct_JJ episodes_NNS of_IN lower_JJR
        respiratory_JJ infection_NN ,_, giving_VBG an_DT overall_JJ annual_JJ incidence_NN
        rate_NN of_IN episodes_NNS of_IN LRI_NNP coming_VBG to_TO medical_JJ attention_NN of_IN
        93_CD /_NN 1_CD ,_, 000_CD person-years_JJ ._.
        Annual_NNP LRI_NNP episode_NN incidence_NN rates_NNS are_VBP shown_VBN in_IN Table_NNP
        1_CD and_CC Figure_NN 2_CD by_IN age_NN group_NN and_CC gender_NN ._. These_DT incidence_NN rates_NNS
        are_VBP highest_JJS among_IN pre-school_JJ children_NNS after_IN the_DT first_JJ year_NN
        of_IN life_NN and_CC among_IN those_DT 85_CD years_NNS and_CC older_JJR ._. In_IN those_DT
        categories_NNS ,_, the_DT rates_NNS for_IN boys_NNS and_CC men_NNS exceeded_VBD those_DT for_IN
        girls_NNS and_CC women_NNS ,_, by_IN 25_CD %_NN and_CC 45_CD %_NN ,_, respectively_RB ._. In_IN contrast_NN ,_,
        among_IN adults_NNS from_IN 25_CD through_IN 74_CD years_NNS ,_, the_DT rates_NNS among_IN
        women_NNS were_VBD 18_CD %_NN to_TO 34_CD %_NN higher_JJR than_IN those_DT in_IN men_NNS ,_, with_IN the_DT
        largest_JJS excess_JJ in_IN the_DT younger_JJR age_NN groups_NNS ._. The_DT confidence_NN
        intervals_NNS for_IN these_DT rate_NN ratios_NNS excluded_VBD the_DT null_NN in_IN each_DT
        of_IN the_DT age_NN categories_NNS ,_, except_IN 5_CD -_: 24_CD and_CC 75_CD -_: 84_CD years_NNS ._.
        As_IN expected_VBN ,_, there_EX were_VBD many_JJ more_JJR LRI_NNP episodes_NNS during_IN
        the_DT winter_NN ._. The_DT weekly_JJ counts_NNS of_IN these_DT episodes_NNS are_VBP shown_VBN
        in_IN Figure_NN 3_CD ._. The_DT seasonal_JJ variation_NN in_IN these_DT counts_VBZ is_VBZ
        strikingly_RB similar_JJ to_TO the_DT variation_NN in_IN deaths_NNS from_IN
        pneumonia_NN and_CC influenza_NN in_IN 122_CD cities_NNS ,_, reported_VBN by_IN the_DT CDC_NNP
        [_NN 5_CD ]_NN ,_, also_RB shown_VBN in_IN Figure_NN 3_CD ._. For_IN most_JJS winters_NNS ,_, there_EX is_VBZ
        a_DT suggestion_NN that_IN the_DT LRI_NNP episode_NN counts_VBZ rise_NN shortly_RB
        before_IN the_DT peak_NN in_IN deaths_NNS ._.
        Because_IN an_DT important_JJ surveillance_NN goal_NN is_VBZ to_TO detect_VB
        certain_JJ events_NNS ,_, such_JJ as_IN an_DT anthrax_NN exposure_NN ,_, as_RB rapidly_RB as_IN
        possible_JJ ,_, we_PRP show_VBP daily_JJ ,_, rather_RB than_IN weekly_JJ ,_, counts_VBZ in_IN
        Figure_NN 4_CD ._. The_DT left_VBN hand_NN panel_NN ,_, with_IN over_IN 1_CD ,_, 400_CD data_NNS points_NNS ,_,
        also_RB makes_VBZ evident_JJ the_DT overall_JJ seasonal_JJ variation_NN in_IN
        disease_NN incidence_NN ,_, though_IN with_IN considerably_RB more_JJR scatter_NN ._.
        This_DT figure_NN also_RB shows_VBZ that_IN diagnoses_NNS are_VBP much_RB less_RBR likely_JJ
        to_TO be_VB assigned_VBN on_IN weekend_NN days_NNS ._. The_DT right_JJ hand_NN panel_NN ,_, which_WDT
        shows_VBZ daily_JJ counts_NNS for_IN a_DT single_JJ month_NN demonstrates_VBZ more_RBR
        clearly_RB the_DT day_NN to_TO day_NN variation_NN in_IN occurrence_NN of_IN LRI_NNP
        episodes_NNS ._. The_DT lower_JJR weekend_NN counts_NNS are_VBP seen_VBN ,_, usually_RB
        followed_VBN by_IN the_DT week_NN 's_POS highest_JJS counts_VBZ on_IN Mondays_NNS ._. However_RB ,_,
        the_DT overall_JJ day_NN to_TO day_NN variation_NN in_IN counts_VBZ is_VBZ relatively_RB
        large_JJ ,_, making_VBG it_PRP difficult_JJ to_TO discern_VB important_JJ overall_JJ
        trends_NNS in_IN disease_NN incidence_NN ._. This_DT difficulty_NN is_VBZ evident_JJ
        even_RB in_IN this_DT best_JJS case_NN situation_NN in_IN which_WDT all_DT of_IN the_DT events_NNS
        in_IN greater_JJR Boston_NNP are_VBP aggregated_JJ ._.
        In_IN Figure_NN 5_CD we_PRP show_VBP disease_NN patterns_NNS in_IN space_NN as_RB well_RB as_IN
        time_NN ._. Episodes_NNP are_VBP assigned_VBN to_TO the_DT census_NN block_NN group_NN in_IN
        which_WDT the_DT individual_JJ resides_VBZ ._. The_DT four_CD panels_NNS in_IN the_DT figure_NN
        show_NN intervals_NNS ranging_VBG from_IN the_DT entire_JJ four_CD years_NNS to_TO a_DT
        single_JJ day_NN ._. For_IN intervals_NNS as_RB small_JJ as_IN a_DT week_NN ,_, the_DT overall_JJ
        geographic_JJ clustering_VBG of_IN episodes_NNS ,_, corresponding_JJ to_TO the_DT
        concentration_NN of_IN residents_NNS who_WP receive_VBP care_NN from_IN Harvard_NNP
        Vanguard_NNP ,_, is_VBZ reasonably_RB well_RB preserved_VBN ._. The_DT small_JJ number_NN of_IN
        events_NNS in_IN any_DT locale_NN is_VBZ well_RB demonstrated_VBN ,_, however_RB ._. A_DT
        similar_JJ display_NN of_IN rates_NNS ,_, rather_RB than_IN counts_VBZ would_MD show_VB
        much_RB less_JJR variation_NN ._.
      
      
        Discussion_NNP
        Routinely_NNP collected_VBD medical_JJ record_NN information_NN has_VBZ
        several_JJ important_JJ advantages_NNS for_IN surveillance_NN purposes_NNS ,_, and_CC
        particularly_RB for_IN the_DT surveillance_NN of_IN infection_NN syndromes_NNS ._.
        Among_IN the_DT most_RBS important_JJ is_VBZ the_DT ability_NN to_TO assess_VB the_DT large_JJ
        majority_NN of_IN episodes_NNS of_IN illness_NN for_IN which_WDT no_DT etiologic_JJ
        agents_NNS are_VBP identified_VBN ,_, either_CC because_IN good_JJ medical_JJ practice_NN
        does_VBZ not_RB require_VB that_IN clinicians_NNS perform_VBP diagnostic_JJ tests_NNS ,_,
        or_CC because_IN an_DT unusual_JJ agent_NN may_MD fail_VB to_TO be_VB detected_VBN by_IN
        standard_JJ laboratory_NN tests_NNS ._. Syndromic_NNP surveillance_NN should_MD
        thus_RB be_VB useful_JJ both_DT for_IN tracking_VBG the_DT activity_NN of_IN infectious_JJ
        agents_NNS that_WDT are_VBP common_JJ in_IN communities_NNS ,_, and_CC also_RB for_IN
        identification_NN of_IN new_JJ ,_, emerging_VBG infections_NNS or_CC bioterrorist_NN
        attack_NN ._. The_DT detection_NN of_IN an_DT increased_VBN frequency_NN of_IN events_NNS
        would_MD typically_RB trigger_VB more_RBR intensive_JJ assessment_NN ,_,
        including_VBG more_RBR diagnostic_JJ testing_NN than_IN would_MD ordinarily_RB be_VB
        indicated_VBN ._. Syndromic_NNP surveillance_NN also_RB allows_VBZ the_DT earliest_JJS
        possible_JJ identification_NN of_IN increased_VBN disease_NN frequency_NN ,_,
        presumably_RB days_NNS before_IN laboratory_NN test_NN results_NNS become_VBP
        available_JJ ._. This_DT early_JJ indication_NN of_IN a_DT problem_NN may_MD be_VB
        important_JJ in_IN detecting_VBG and_CC responding_VBG to_TO a_DT bioterrorist_NN
        attack_NN ,_, for_IN instance_NN the_DT release_NN of_IN anthrax_NN in_IN a_DT
        community_NN ._.
        Other_JJ advantages_NNS of_IN automated_VBN diagnosis_NN data_NNS for_IN
        surveillance_NN include_VBP uniformity_NN and_CC increased_VBN sensitivity_NN
        of_IN detection_NN ,_, since_IN clinicians_NNS are_VBP not_RB required_VBN to_TO
        recognize_VB a_DT condition_NN as_IN being_NN of_IN interest_NN ._. These_DT data_NNS also_RB
        circumvent_VB the_DT need_NN for_IN providers_NNS to_TO initiate_VB reporting_VBG ,_, an_DT
        important_JJ consideration_NN in_IN light_NN of_IN the_DT time_NN pressures_NNS that_WDT
        constrain_VB existing_VBG reporting_VBG ._. For_IN some_DT purposes_NNS ,_, automated_VBN
        methods_NNS may_MD augment_VB or_CC replace_VB resource_NN intensive_JJ sentinel_NN
        surveillance_NN programs_NNS ,_, for_IN example_NN those_DT described_VBN by_IN
        Armstrong_NNP [_NN 6_CD ]_NN and_CC de_IN Wit_NNP [_NN 7_CD ]_NN ,_, that_WDT have_VBP been_VBN created_VBN
        to_TO collect_VB information_NN that_WDT is_VBZ n't_RB captured_VBN by_IN standard_JJ
        reporting_NN systems_NNS ._. Finally_RB ,_, data_NNS from_IN automated_VBN medical_JJ
        record_NN systems_NNS lend_VBP themselves_PRP well_RB to_TO incorporation_NN in_IN
        automated_VBN detection_NN systems_NNS with_IN little_JJ or_CC no_DT added_VBN cost_VBN ,_,
        because_IN the_DT data_NNS are_VBP available_JJ in_IN electronic_JJ form_NN ,_, avoiding_VBG
        the_DT additional_JJ costs_NNS and_CC errors_NNS due_JJ to_TO data_NNS entry_NN ._.
        For_IN a_DT data_NNS source_NN to_TO be_VB useful_JJ for_IN disease_NN surveillance_NN ,_,
        it_PRP must_MD be_VB timely_JJ ,_, accurate_JJ ,_, complete_JJ ,_, and_CC capable_JJ of_IN
        distinguishing_VBG events_NNS of_IN interest_NN from_IN background_NN
        occurrences_NNS ,_, i_NNP ._. e_SYM ._. ,_, an_DT acceptable_JJ signal_NN to_TO noise_NN ratio_NN ._. The_DT
        interval_NN between_IN a_DT patient_NN being_VBG seen_VBN and_CC data_NNS being_VBG
        available_JJ for_IN analysis_NN must_MD be_VB short_JJ ,_, particularly_RB in_IN any_DT
        bioterrorist_NN threat_NN situation_NN ._. Diagnostic_NNP and_CC demographic_JJ
        accuracy_NN are_VBP needed_VBN in_IN order_NN to_TO enable_VB reliable_JJ evaluation_NN
        of_IN geographic_JJ clustering_VBG of_IN specific_JJ emerging_VBG infections_NNS or_CC
        syndromes_NNS ._. Complete_JJ data_NNS or_CC at_IN least_JJS reasonably_RB complete_JJ
        sampling_VBG is_VBZ essential_JJ if_IN events_NNS of_IN relatively_RB small_JJ scale_NN
        are_VBP to_TO be_VB detected_VBN ._.
        In_IN terms_NNS of_IN timeliness_NNS ,_, this_DT ambulatory_JJ record_NN
        information_NN can_MD be_VB available_JJ very_RB quickly_RB ._. In_IN practice_NN ,_, it_PRP
        is_VBZ efficient_JJ extract_NN each_DT day_NN 's_POS visits_NNS of_IN interest_NN during_IN
        the_DT succeeding_VBG night_NN ,_, thus_RB making_VBG the_DT information_NN available_JJ
        within_IN 24_CD hours_NNS of_IN the_DT patient_NN encounter_NN ._.
        In_IN terms_NNS of_IN accuracy_NN ,_, the_DT data_NNS are_VBP probably_RB of_IN
        acceptable_JJ reliability_NN for_IN patient_NN demographics_NNS and_CC
        encounter_VB dates_NNS ,_, since_IN this_DT information_NN comes_VBZ from_IN the_DT
        administrative_JJ database_NN used_VBN for_IN reimbursement_NN ._. The_DT
        validity_NN or_CC reliability_NN of_IN physician_NN diagnosis_NN in_IN terms_NNS of_IN
        ICD_NNP 9_CD codes_NNS is_VBZ neither_DT known_VBN nor_CC readily_RB amenable_JJ to_TO
        measurement_NN ._. In_IN other_JJ settings_NNS ,_, ICD_NNP 9_CD codes_NNS have_VBP been_VBN shown_VBN
        to_TO have_VB substantial_JJ discrepancies_NNS ,_, when_WRB they_PRP are_VBP compared_VBN
        to_TO the_DT information_NN in_IN the_DT full_JJ text_NN medical_JJ record_NN [_NN 8_CD ]_NN ._.
        We_PRP expect_VBP that_IN the_DT diagnoses_NNS of_IN interest_NN here_RB also_RB have_VBP
        substantial_JJ errors_NNS that_WDT reduce_VBP both_DT sensitivity_NN and_CC
        specificity_NN ._. It_PRP is_VBZ likely_JJ that_IN these_DT errors_NNS are_VBP relatively_RB
        stable_JJ over_IN the_DT time_NN periods_NNS of_IN interest_NN for_IN surveillance_NN
        of_IN acute_JJ disease_NN syndromes_NNS ,_, and_CC so_IN this_DT problem_NN may_MD not_RB
        interfere_VB appreciably_RB with_IN day_NN to_TO day_NN comparisons_NNS ._. However_RB ,_,
        there_EX could_MD be_VB important_JJ differences_NNS attributable_JJ to_TO coding_VBG
        practices_NNS between_IN groups_NNS of_IN clinicians_NNS ,_, or_CC in_IN different_JJ
        medical_JJ record_NN systems_NNS ,_, for_IN instance_NN if_IN the_DT automated_VBN
        systems_NNS guide_NN clinicians_NNS to_TO choose_VB certain_JJ codes_NNS over_IN
        others_NNS ._.
        The_DT lack_NN of_IN uniformity_NN in_IN the_DT use_NN of_IN ICD_NNP 9_CD codes_NNS ,_, for_IN
        instance_NN in_IN assigning_VBG a_DT diagnosis_NN of_IN pneumonia_NN ,_, may_MD be_VB
        ameliorated_JJ by_IN grouping_VBG diagnoses_NNS into_IN broader_JJR syndromic_JJ
        surveillance_NN categories_NNS ,_, as_IN was_VBD done_VBN for_IN this_DT report_NN ._. It_PRP is_VBZ
        notable_JJ that_IN the_DT relatively_RB non-specific_JJ diagnosis_NN of_IN
        "_'' cough_NN "_'' accounted_VBD for_IN more_JJR than_IN half_NN of_IN LRI_NNP encounters_VBZ
        studied_VBN here_RB ._. At_IN this_DT time_NN ,_, we_PRP have_VBP no_DT simple_JJ way_NN to_TO
        measure_VB directly_RB the_DT accuracy_NN of_IN coding_VBG or_CC of_IN directly_RB
        assessing_VBG the_DT effect_NN of_IN syndromic_JJ groupings_NNS ._. No_DT standard_JJ
        syndromic_JJ grouping_VBG is_VBZ yet_RB in_IN wide_JJ use_NN for_IN surveillance_NN
        purposes_NNS ._. The_DT provisional_JJ grouping_VBG used_VBN in_IN this_DT report_NN was_VBD
        developed_VBN by_IN the_DT U_NNP ._. S_NNP ._. Department_NNP of_IN Defense_NNP for_IN its_PRP$ own_JJ
        specific_JJ needs_VBZ but_CC appears_VBZ to_TO have_VB worked_VBN reasonably_RB well_RB
        with_IN the_DT ambulatory_JJ care_NN data_NNS described_VBD here_RB ._. Because_IN a_DT
        small_JJ number_NN of_IN relatively_RB non-specific_JJ codes_NNS (_( cough_NN ,_,
        pneumonia_NN ,_, bronchitis_NNS )_) account_NN for_IN the_DT large_JJ majority_NN of_IN
        episodes_NNS of_IN lower_JJR respiratory_JJ infection_NN ,_, it_PRP is_VBZ likely_JJ that_IN
        most_JJS syndrome_NN groupings_NNS will_MD yield_VB very_RB similar_JJ results_NNS ._.
        Although_IN the_DT inclusion_NN of_IN symptoms_NNS like_IN cough_NN clearly_RB
        reduces_VBZ specificity_NN ,_, we_PRP believe_VBP this_DT is_VBZ outweighed_VBN by_IN the_DT
        gain_NN in_IN sensitivity_NN ._. This_DT tradeoff_NN is_VBZ discussed_VBN in_IN more_JJR
        detail_NN below_IN ._.
        In_IN terms_NNS of_IN completeness_NN ,_, an_DT automated_VBN system_NN like_IN the_DT
        one_CD we_PRP describe_VBP here_RB is_VBZ typically_RB as_IN complete_JJ for_IN
        ambulatory_JJ encounters_NNS as_IN the_DT records_NNS that_IN clinicians_NNS
        maintain_VBP ._. Our_PRP$ belated_JJ discovery_NN that_IN some_DT encounters_NNS of_IN
        interest_NN were_VBD missing_VBG from_IN the_DT analysis_NN dataset_NN adds_VBZ an_DT
        important_JJ cautionary_JJ note_NN ,_, however_RB ,_, about_IN the_DT potential_JJ
        problems_NNS in_IN adapting_VBG data_NNS designed_VBN for_IN one_CD purpose_NN to_TO
        another_DT one_CD ._. We_PRP believe_VBP the_DT omission_NN of_IN emergency_NN room_NN
        visits_NNS has_VBZ a_DT minor_JJ impact_NN on_IN the_DT total_JJ number_NN of_IN events_NNS ,_,
        since_IN their_PRP$ number_NN is_VBZ small_JJ in_IN relation_NN to_TO the_DT total_JJ number_NN
        of_IN ambulatory_JJ visits_NNS ._. However_RB ,_, surveillance_NN based_VBN in_IN
        emergency_NN rooms_NNS is_VBZ also_RB of_IN great_JJ value_NN ._. We_PRP see_VBP the_DT system_NN
        described_VBD here_RB as_IN being_VBG complementary_JJ to_TO emergency_NN room_NN
        based_VBD systems_NNS ._. A_DT potential_JJ advantage_NN of_IN assessment_NN of_IN
        office_NN visits_NNS is_VBZ the_DT possibility_NN that_IN it_PRP will_MD provide_VB an_DT
        earlier_JJR signal_NN than_IN will_MD an_DT emergency_NN room_NN based_VBD detection_NN
        system_NN if_IN the_DT condition_NN of_IN interest_NN begins_VBZ with_IN symptoms_NNS
        that_WDT do_VBP n't_RB warrant_VB emergency_NN room_NN care_NN ._.
        The_DT use_NN of_IN data_NNS from_IN an_DT automated_VBN medical_JJ record_NN system_NN
        in_IN a_DT health_NN care_NN environment_NN linked_VBN to_TO individuals_NNS '_POS
        insurance_NN coverage_NN provides_VBZ an_DT additional_JJ reason_NN to_TO believe_VB
        the_DT data_NNS are_VBP reasonably_RB complete_JJ ,_, since_IN individuals_NNS have_VBP a_DT
        strong_JJ financial_JJ incentive_NN to_TO receive_VB their_PRP$ care_NN from_IN
        providers_NNS whose_WP$ clinical_JJ encounter_NN information_NN is_VBZ reported_VBN
        to_TO the_DT insurer_NN for_IN reimbursement_NN purposes_NNS ._. It_PRP may_MD also_RB be_VB
        possible_JJ to_TO make_VB similar_JJ use_NN of_IN diagnoses_NNS contained_VBD in_IN
        automated_VBN billing_NN data_NNS ,_, rather_RB than_IN automated_VBN medical_JJ
        records_NNS ._. Although_IN most_JJS current_JJ administrative_JJ systems_NNS
        include_VBP time_NN lags_VBZ that_WDT diminish_VBP their_PRP$ utility_NN ,_, the_DT
        development_NN of_IN on-line_JJ transaction_NN processing_NN between_IN
        clinicians_NNS and_CC payers_NNS may_MD reduce_VB or_CC eliminate_VB that_DT
        deficiency_NN ._. All_DT medical_JJ records_NNS or_CC claims_NNS based_VBD systems_NNS
        depend_VBP ,_, of_IN course_NN ,_, on_IN individuals_NNS '_POS bringing_VBG the_DT event_NN to_TO
        clinicians_NNS '_POS attention_NN ._. Such_JJ systems_NNS provide_VBP no_DT information_NN
        about_IN the_DT large_JJ number_NN of_IN illnesses_NNS that_WDT resolve_NN without_IN
        formal_JJ contact_NN with_IN the_DT medical_JJ system_NN ._.
        Even_RB large_JJ health_NN plans_NNS typically_RB include_VBP only_RB a_DT portion_NN
        of_IN individuals_NNS in_IN a_DT community_NN ._. Although_IN the_DT number_NN of_IN
        individuals_NNS may_MD be_VB sufficient_JJ for_IN surveillance_NN purposes_NNS ,_, it_PRP
        will_MD be_VB important_JJ to_TO assess_VB the_DT degree_NN to_TO which_WDT the_DT covered_VBN
        population_NN resembles_VBZ the_DT entire_JJ population_NN ._. Insured_NNP
        populations_NNS are_VBP likely_JJ to_TO be_VB adequate_JJ for_IN many_JJ conditions_NNS
        of_IN interest_NN ,_, especially_RB if_IN one_CD adjusts_VBZ for_IN major_JJ
        determinants_NNS of_IN illness_NN ._.
        An_DT additional_JJ advantage_NN of_IN using_VBG automated_VBN data_NNS from_IN
        health_NN plans_NNS is_VBZ the_DT ability_NN to_TO know_VB the_DT exact_JJ size_NN ,_,
        composition_NN ,_, and_CC residence_NN location_NN of_IN the_DT source_NN
        population_NN ._. Although_IN we_PRP limited_JJ our_PRP$ characterization_NN of_IN the_DT
        population_NN to_TO age_NN and_CC sex_NN ,_, it_PRP is_VBZ also_RB possible_JJ to_TO use_VB more_RBR
        detailed_JJ information_NN about_IN disease_NN history_NN ,_, for_IN instance_NN to_TO
        characterize_VB the_DT burden_NN of_IN illness_NN among_IN individuals_NNS with_IN
        specific_JJ chronic_JJ diseases_NNS ._. Locating_NNP clusters_NNS of_IN illness_NN
        should_MD have_VB great_JJ utility_NN for_IN identifying_VBG and_CC remedying_VBG
        localized_JJ disease_NN sources_NNS ;_: these_DT might_MD be_VB locations_NNS ,_, such_JJ
        as_IN day_NN care_NN facilities_NNS ,_, where_WRB infection_NN is_VBZ transmitted_VBN
        person_NN to_TO person_NN ,_, or_CC areas_NNS in_IN which_WDT there_EX are_VBP environmental_JJ
        sources_NNS of_IN infection_NN ,_, such_JJ as_IN a_DT contaminated_JJ water_NN supply_NN ._.
        The_DT geographical_JJ information_NN available_JJ to_TO health_NN plan_NN is_VBZ
        primarily_RB useful_JJ ,_, of_IN course_NN ,_, for_IN conditions_NNS whose_WP$ source_NN is_VBZ
        near_IN individuals_NNS '_POS homes_NNS ._.
        Primary_JJ medical_JJ records_NNS will_MD include_VB multiple_JJ encounters_NNS
        within_IN a_DT single_JJ episode_NN of_IN infection_NN for_IN some_DT patients_NNS ._. The_DT
        decision_NN to_TO define_VB a_DT new_JJ episode_NN on_IN the_DT basis_NN of_IN six_CD weeks_NNS
        free_JJ from_IN any_DT LRI_NNP coded_VBN encounter_VB was_VBD based_VBN on_IN a_DT
        combination_NN of_IN clinical_JJ experience_NN and_CC the_DT pattern_NN of_IN
        repeated_VBN encounters_NNS ._. For_IN surveillance_NN systems_NNS to_TO be_VB
        comparable_JJ ,_, the_DT classification_NN of_IN encounters_NNS into_IN episodes_NNS
        of_IN illness_NN is_VBZ an_DT important_JJ methodological_JJ problem_NN that_WDT
        deserves_VBZ additional_JJ attention_NN ._. It_PRP is_VBZ possible_JJ ,_, for_IN
        instance_NN ,_, that_IN the_DT pattern_NN of_IN repeat_NN visits_NNS might_MD change_VB
        during_IN a_DT cluster_NN of_IN illness_NN ._. Although_IN the_DT distribution_NN of_IN
        LRI_NNP visit_NN intervals_NNS supports_VBZ a_DT six_CD week_NN disease_NN free_JJ
        interval_NN to_TO become_VB eligible_JJ for_IN a_DT second_JJ episode_NN ,_, other_JJ
        cutoffs_NNS might_MD also_RB have_VB been_VBN chosen_VBN ._.
        It_PRP seems_VBZ reasonable_JJ to_TO assume_VB that_IN if_IN similar_JJ patterns_NNS
        of_IN illness_NN in_IN time_NN and_CC space_NN are_VBP observed_VBN in_IN other_JJ systems_NNS
        (_( such_JJ as_IN specific_JJ disease_NN surveillance_NN systems_NNS ,_, hospital_NN
        discharge_NN records_NNS ,_, or_CC other_JJ large_JJ ambulatory_JJ care_NN record_NN
        systems_NNS )_) ,_, then_RB this_DT provides_VBZ some_DT degree_NN of_IN criterion_NN
        validity_NN for_IN the_DT data_NNS presented_VBN here_RB ._. The_DT striking_JJ
        similarity_NN in_IN seasonal_JJ variation_NN between_IN our_PRP$ LRI_NNP episodes_NNS
        and_CC the_DT national_JJ experience_NN with_IN pneumonia_NN and_CC influenza_NN
        deaths_NNS provides_VBZ one_CD measure_NN of_IN assurance_NN that_IN our_PRP$ system_NN
        identified_VBD relevant_JJ events_NNS ._. We_PRP also_RB compared_VBD the_DT CDC_NNP 's_POS
        pneumonia_NN and_CC influenza_NN death_NN data_NNS for_IN Boston_NNP to_TO our_PRP$
        experience_NN ,_, but_CC the_DT number_NN of_IN reported_VBD deaths_NNS was_VBD too_RB small_JJ
        for_IN meaningful_JJ seasonal_JJ patterns_NNS to_TO emerge_VB ._. Additional_JJ
        support_NN for_IN the_DT utility_NN of_IN medical_JJ record_NN surveillance_NN
        information_NN comes_VBZ from_IN comparison_NN of_IN our_PRP$ data_NNS to_TO that_DT
        collected_VBN by_IN the_DT National_NNP Ambulatory_NNP Medical_NNP Care_NNP Survey_NNP
        (_( NAMCS_NNP )_) [_NN 9_CD ]_NN ,_, which_WDT uses_VBZ multistage_NN sampling_VBG of_IN
        ambulatory_JJ care_NN physicians_NNS ,_, requiring_VBG participants_NNS to_TO
        report_VB a_DT random_JJ sample_NN of_IN patients_NNS seen_VBN in_IN a_DT randomly_RB
        assigned_VBN week_NN ._. For_IN the_DT period_NN 1990_CD to_TO 1996_CD ,_, the_DT estimated_VBN
        rate_NN for_IN lower_JJR respiratory_JJ infection_NN office_NN visits_NNS was_VBD
        74_CD ._. 2_LS /_NN 1000_CD population_NN per_IN year_NN ,_, based_VBN on_IN about_IN 40_CD ,_, 000_CD
        sampled_VBN records_NNS per_IN year_NN nationally_RB ._. This_DT estimate_NN is_VBZ
        reasonably_RB close_RB to_TO our_PRP$ observed_JJ rate_NN of_IN 93_CD /_NN 1000_CD ._. The_DT
        difference_NN between_IN the_DT two_CD rates_NNS may_MD be_VB due_JJ in_IN part_NN to_TO
        sampling_VBG variation_NN (_( principally_RB arising_VBG from_IN the_DT smaller_JJR
        NAMCS_NNP sample_NN )_) ,_, differences_NNS in_IN the_DT age_NN /_NN comorbidity_NN profiles_NNS
        of_IN the_DT populations_NNS ,_, greater_JJR sensitivity_NN of_IN the_DT HVMA_NNP sample_NN
        because_IN it_PRP included_VBD telephone_NN encounters_VBZ ,_, and_CC lack_NN of_IN
        specificity_NN of_IN the_DT cough_NN diagnosis_NN ._. In_IN any_DT event_NN ,_, the_DT
        difference_NN ,_, even_RB if_IN real_JJ ,_, should_MD not_RB seriously_RB interfere_VB
        with_IN the_DT utility_NN of_IN this_DT syndromic_JJ surveillance_NN system_NN to_TO
        identify_VB overall_JJ disease_NN trends_NNS or_CC provide_VB early_JJ warning_NN of_IN
        illness_NN clusters_NNS ._.
        Similarly_RB ,_, the_DT age_NN and_CC sex_NN distribution_NN of_IN these_DT cases_NNS
        is_VBZ consistent_JJ with_IN our_PRP$ knowledge_NN of_IN the_DT epidemiology_NN of_IN
        lower_JJR respiratory_JJ tract_NN infection_NN ._. Others_NNS ,_, using_VBG data_NNS from_IN
        an_DT office_NN practice_NN ,_, have_VBP shown_VBN an_DT early_JJ childhood_NN peak_NN at_IN
        approximately_RB one_CD year_NN ,_, also_RB with_IN higher_JJR rates_NNS in_IN males_NNS of_IN
        approximately_RB 25_CD %_NN [_NN 10_CD ]_NN ._. The_DT increasing_VBG rate_NN with_IN age_NN
        among_IN adults_NNS has_VBZ been_VBN widely_RB recognized_VBN ,_, along_IN with_IN an_DT
        overall_JJ male_JJ predominance_NN [_NN 11_CD 12_CD 13_CD ]_NN ._. Some_DT studies_NNS have_VBP
        reported_VBN either_CC a_DT smaller_JJR difference_NN between_IN men_NNS and_CC women_NNS
        among_IN younger_JJR adults_NNS [_NN 12_CD ]_NN ,_, or_CC an_DT excess_NN among_IN younger_JJR
        adult_NN women_NNS [_NN 11_CD ]_NN ,_, as_IN observed_VBN in_IN our_PRP$ population_NN ._. Our_PRP$
        data_NNS do_VBP not_RB distinguish_VB between_IN actual_JJ differences_NNS in_IN
        disease_NN incidence_NN by_IN age_NN and_CC sex_NN ,_, and_CC differential_NN
        ascertainment_NN ,_, either_CC because_IN of_IN differences_NNS in_IN likelihood_NN
        of_IN seeking_VBG health_NN care_NN or_CC differences_NNS in_IN the_DT way_NN clinicians_NNS
        code_NN encounters_VBZ for_IN men_NNS and_CC women_NNS ._.
        In_IN order_NN to_TO distinguish_VB signals_NNS of_IN interest_NN from_IN
        background_NN occurrences_NNS ,_, we_PRP believe_VBP it_PRP will_MD be_VB necessary_JJ to_TO
        develop_VB statistical_JJ methods_NNS to_TO identify_VB unusual_JJ clusters_NNS
        that_WDT deserve_VBP further_JJ attention_NN ._. The_DT volume_NN of_IN data_NNS acquired_VBN
        is_VBZ so_RB large_JJ that_IN it_PRP is_VBZ impractical_JJ to_TO perform_VB manual_JJ daily_JJ
        inspection_NN of_IN data_NNS from_IN a_DT large_JJ geographically_RB dispersed_VBD
        population_NN ._. This_DT is_VBZ especially_RB important_JJ since_IN there_EX were_VBD
        only_RB twelve_CD lower_JJR respiratory_JJ infection_NN syndrome_NN clusters_NNS
        each_DT year_NN of_IN more_RBR than_IN approximately_RB five_CD events_NNS occurring_VBG
        in_IN a_DT single_JJ day_NN among_IN health_NN plan_NN members_NNS residing_VBG in_IN a_DT
        single_JJ census_NN tract_NN (_( authors_NNS '_POS unpublished_JJ data_NNS )_) ._. The_DT
        specific_JJ number_NN of_IN events_NNS required_VBN to_TO be_VB included_VBN in_IN the_DT
        twelve_CD most_RBS extreme_JJ clusters_NNS depended_VBD on_IN the_DT number_NN of_IN
        health_NN plan_NN members_NNS in_IN a_DT census_NN tract_NN ,_, as_RB well_RB as_IN the_DT month_NN
        of_IN the_DT year_NN ,_, and_CC the_DT day_NN of_IN the_DT week_NN ._.
        The_DT fact_NN that_IN relatively_RB few_JJ events_NNS occurred_VBD on_IN any_DT
        particular_JJ day_NN in_IN any_DT census_NN tract_NN supports_VBZ our_PRP$ inclusion_NN
        of_IN the_DT "_'' cough_NN "_'' diagnosis_NN in_IN the_DT syndrome_NN definition_NN ,_, in_IN
        order_NN to_TO improve_VB the_DT sensitivity_NN of_IN our_PRP$ case_NN finding_NN ._.
        Although_IN this_DT is_VBZ a_DT non-specific_JJ diagnosis_NN ,_, and_CC it_PRP accounted_VBD
        for_IN a_DT majority_NN of_IN all_DT events_NNS ,_, the_DT total_JJ number_NN of_IN these_DT was_VBD
        not_RB so_RB large_JJ that_IN it_PRP compromised_VBN the_DT utility_NN of_IN this_DT
        particular_JJ surveillance_NN system_NN ._. An_DT enhancement_NN that_WDT may_MD be_VB
        useful_JJ in_IN automated_VBN medical_JJ record_NN systems_NNS ,_, but_CC not_RB in_IN
        claims_NNS based_VBD systems_NNS ,_, is_VBZ to_TO require_VB fever_NN (_( measured_VBN value_NN ,_,
        not_RB ICD_NNP 9_CD code_NN )_) to_TO be_VB part_NN of_IN the_DT definition_NN of_IN a_DT lower_JJR
        respiratory_JJ infection_NN ._. This_DT would_MD presumably_RB preserve_VB
        sensitivity_NN for_IN conditions_NNS like_IN anthrax_NN ,_, and_CC also_RB reduce_VB
        the_DT number_NN of_IN false_JJ positive_JJ clinical_JJ events_NNS ._.
        To_TO the_DT extent_NN this_DT surveillance_NN method_NN proves_VBZ useful_JJ ,_, it_PRP
        will_MD be_VB worthwhile_JJ to_TO extend_VB it_PRP to_TO other_JJ conditions_NNS that_WDT
        cluster_NN in_IN the_DT areas_NNS of_IN residence_NN of_IN affected_VBN individuals_NNS ._.
        Within_IN infectious_JJ diseases_NNS ,_, these_DT might_MD include_VB diseases_NNS
        spread_VBP by_IN airborne_JJ dissemination_NN in_IN residential_JJ areas_NNS ,_, by_IN
        contaminated_JJ foods_NNS or_CC water_NN distributed_VBN to_TO residents_NNS of_IN a_DT
        neighborhood_NN ,_, by_IN insect_NN or_CC other_JJ animal_NN vectors_NNS ,_, or_CC by_IN
        person-to-person_JJ transmission_NN in_IN households_NNS (_( secondary_JJ
        spread_NN )_) ._. Specific_JJ infection_NN syndromes_NNS of_IN interest_NN ,_, in_IN
        addition_NN to_TO lower_JJR respiratory_JJ infection_NN ,_, include_VBP upper_JJ
        respiratory_JJ infection_NN ,_, gastrointestinal_NN disease_NN ,_, neurologic_JJ
        disease_NN ,_, and_CC rash_NN ._. It_PRP may_MD also_RB be_VB useful_JJ for_IN other_JJ
        conditions_NNS that_WDT may_MD be_VB clustered_VBN in_IN time_NN or_CC space_NN ,_, such_JJ as_IN
        injuries_NNS ._.
        We_PRP conclude_VBP that_IN as_IN automated_VBN ambulatory_JJ care_NN record_NN
        systems_NNS become_VBP more_RBR widely_RB available_JJ ,_, they_PRP can_MD assume_VB an_DT
        important_JJ ,_, currently_RB unfilled_JJ ,_, role_NN in_IN disease_NN
        surveillance_NN ._. Such_JJ systems_NNS are_VBP less_RBR prone_JJ to_TO undercounting_VBG
        than_IN traditional_JJ public_JJ health_NN reporting_VBG systems_NNS ,_, and_CC they_PRP
        are_VBP less_JJR resource_NN intensive_JJ than_IN traditional_JJ sentinel_NN
        surveillance_NN systems_NNS ._. These_DT data_NNS can_MD serve_VB several_JJ
        different_JJ purposes_NNS ,_, including_VBG informing_VBG clinicians_NNS of_IN
        conditions_NNS that_WDT are_VBP prevalent_JJ in_IN their_PRP$ communities_NNS ,_,
        providing_VBG detailed_JJ and_CC timely_JJ information_NN to_TO health_NN plans_NNS
        that_WDT need_VBP to_TO allocate_VB scarce_JJ resources_NNS ,_, and_CC to_TO public_JJ
        health_NN programs_NNS to_TO allow_VB early_JJ recognition_NN and_CC response_NN to_TO
        changing_VBG disease_NN patterns_NNS ._. Suitably_NNP de-identified_JJ
        electronic_JJ data_NNS could_MD be_VB provided_VBN to_TO public_JJ health_NN systems_NNS
        in_IN a_DT format_NN consistent_JJ with_IN the_DT emerging_VBG National_NNP
        Electronic_NNP Disease_NNP Surveillance_NNP System_NNP (_( NEDSS_NNP )_) standards_NNS [_NN
        14_CD ]_NN ._. Inclusion_NNP of_IN such_JJ reporting_NN capability_NN ,_, under_IN
        clinicians_NNS '_POS and_CC health_NN systems_NNS '_POS control_NN ,_, in_IN commercial_JJ
        medical_JJ record_NN systems_NNS is_VBZ likely_JJ to_TO be_VB an_DT inexpensive_JJ way_NN
        to_TO provide_VB the_DT required_JJ data_NN in_IN the_DT most_RBS usable_JJ form_NN ._. The_DT
        timely_JJ use_NN of_IN automated_VBN diagnosis_NN information_NN ,_, especially_RB
        with_IN cluster_NN detection_NN algorithms_NNS ,_, may_MD be_VB a_DT valuable_JJ
        resource_NN for_IN supplementing_VBG current_JJ infectious_JJ disease_NN
        surveillance_NN systems_NNS ._.
      
      
        List_NN of_IN abbreviations_NNS
        HMO_NNP :_: Health_NNP maintenance_NN organization_NN
        HPHC_NNP :_: Harvard_NNP Pilgrim_NNP Health_NNP Care_NNP
        HVMA_NNP :_: Harvard_NNP Vanguard_NNP Medical_NNP Associates_NNPS
        ICD_NNP 9_CD CM_NNP :_: International_NNP classification_NN of_IN disease_NN ,_, 9_CD
        thversion_NN ,_, clinical_JJ modification_NN ._.
        LRI_NNP :_: lower_JJR respiratory_JJ tract_NN infection_NN
        NAMCS_NNP :_: National_NNP Ambulatory_NNP Medical_NNP Care_NNP Survey_NNP
        NEDSS_NNP :_: National_NNP Electronic_NNP Disease_NNP Surveillance_NNP
        System_NNP
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD
        Appendix_NNP 1_CD
        List_NN of_IN ICD_NNP 9_CD codes_NNS contributing_VBG to_TO the_DT lower_JJR respiratory_JJ
        infection_NN syndrome_NN group_NN ._.
        Click_NNP here_RB for_IN file_NN
      
    
  
